The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biopsy-driven study to identify biomarkers of drug resistance in patients with triple-negative breast cancer.
Adriana Aguilar-Mahecha
No relevant relationships to disclose
Adriana Aguilar
Disclosure not yet available
Josiane Lafleur
No relevant relationships to disclose
Elaheh Ahmadzadeh
No relevant relationships to disclose
Ewa Przybytkowski
No relevant relationships to disclose
Carole Seguin
No relevant relationships to disclose
Catalin Liviu Dragos Mihalcioiu
No relevant relationships to disclose
Josee-Anne Roy
No relevant relationships to disclose
Christine Desbiens
No relevant relationships to disclose
Andre Robidoux
No relevant relationships to disclose
Elizabeth A. Marcus
No relevant relationships to disclose
Zuanel Diaz
No relevant relationships to disclose
Manuela Pelmus
No relevant relationships to disclose
Gerald Batist
No relevant relationships to disclose
Mark Basik
No relevant relationships to disclose